Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hamilton Medical Research Group is a Canada-based community clinical research organization and trial site network in Hamilton, Ontario, focused on sponsor-led Phase II-IV studies. The organization brings together practicing physicians and research staff under a centralized structure to run site-level clinical trial operations including regulatory submissions, ethics applications, recruitment, clinical assessments, investigational product management, and study close-out. Its work is concentrated in primary care and cardiometabolic, respiratory, renal, and vaccine studies, with named sponsor relationships including Amgen, Novo Nordisk, Eli Lilly, GSK/Bellus Health, Roche/Regeneron, Moderna, and Pfizer. Led by founder and principal investigator Dr. Richard Tytus, HMRG appears to operate as an active research site/service provider rather than a therapeutic product developer with its own proprietary drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hamilton Medical Research Group.